Publicações

Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban. Rationale and Design of the Hot-Pe Trial (Vol 116, Pg 191, 2016)

AuthID
P-00M-4T8

Author(s)

Barco, S

Lankeit, M

Binder, H

Schellong, S

Christ, M

Beyer Westendorf, J

Duerschmied, D

Bauersachs, R

Empen, K

Held, M

Schwaiblmair, M

Fonseca, C

Jimenez, D

Becattini, C

Quitzau, K

Espinola Klein, C

Wild, P

Konstantinides, S

Tipo de Documento

Correction

Year published

2016

Publicado

in THROMBOSIS AND HAEMOSTASIS, ISSN: 0340-6245

Volume: 116, Número: 4, Páginas: 775-775 (1)

Indexing

Wos^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1160/th16100001

Wos: WOS:000384964200026

Source Identifiers

ISSN: 0340-6245

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban. Rationale and Design of the Hot-Pe Trial (Vol 116, Pg 191, 2016)

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban. Rationale and Design of the Hot-Pe Trial (Vol 116, Pg 191, 2016)

Links Úteis

Ajuda